![](https://endpts.com/wp-content/uploads/2023/05/Albert-Bourla-Pfizer-AP-tile1.jpg)
Albert Bourla, Pfizer CEO (Michel Euler/AP Images, Pool)
FDA approves Pfizer’s RSV shot for older adults, teeing up a competitive $17B vaccine market
The FDA approved Pfizer’s RSV vaccine called Abrysvo for older adults on Wednesday, placing another Big Pharma onto the commercial stage ahead of the next …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.